Professor David Adler is a senior pharmaceutical leader in oncology clinical drug development and translational medicine. He spent a decade in senior leadership within Bayer AG’s Global Oncology Clinical Development organization and currently serves as chief scientific and medical officer of the PATHORA Institute of Pathology & Tissue Medicine, alongside academic appointments at the Hebrew University of Jerusalem, Ben-Gurion University of the Negev and the University of Bonn.
